| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |